2019 annual financial data
REGENXBIO 2019 Operating margin
REGENXBIO 2019 operating margin with verified reported values.
Direct answer
Operating margin was -422.89%.
Operating income was -148,998,000 USD and net income was -94,733,000 USD.
Operating cash flow was -107,705,000 USD.
Get free REGENXBIO email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 35,233,000 USD
- Operating income
- -148,998,000 USD
- Net income
- -94,733,000 USD
- Operating cash flow
- -107,705,000 USD